Search results
5 days ago · See the latest Biogen Inc stock price (BIIB:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
3 days ago · Stock analysis for Biogen Inc (BIIB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
- 7.6K
Jun 22, 2024 · Founded in 1978, Biogen Idec is a biotechnology company specializing in treatments in the areas of immunology and neurology. The company's name-brand drugs include Avonex (for multiple sclerosis), Tysabri (for multiple sclerosis and Crohn's disease), Rituxan (developed jointly with Genentech for the treatment of non-Hodgkin's ...
6 days ago · Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental ...
Jun 15, 2024 · Biogen is a biotechnology company that discovers, develops, and delivers therapies for people living with serious neurological and neurodegenerative diseases. It is primarily focused on developing medicines to treat multiple sclerosis, spinal muscular atrophy, Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral ...
- 7.4K
Jun 27, 2024 · Tracing its lineage, the Biogen logo’s evolution parallels the development of DNA sequencing, each iteration marking milestones in biopharmaceuticals. Its conception, much like the genesis of Biogen Idec, was marked by a drive to disrupt and redefine the boundaries of healthcare technology companies.
Jun 30, 2024 · Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1% ...
